|
|
||||||||||||||
|
|
|||||||||||||||
University Department of Pathology, Southampton General Hospital.
AIM: To review the presenting clinical features and the histology of cases of non-Hodgkin lymphoma (NHL) entered into the United Kingdom Children's Cancer Study Group NHL Trial. METHODS: Sections of biopsy specimens from all cases entered into the trial were stained with Giemsa and haematoxylin and eosin. All cases were stained immunohistochemically for CD45, CD3, CD45RO, CD20, and CD30. Sections were stained with either naphthol AS-D chloroacetate esterase or KP1 (CD68) to identify granulocytic tumours. In a minority of cases, additional immunohistochemical stains were performed when necessary to establish the diagnosis. The sections were reviewed by three pathologists. RESULTS: Of 308 cases analysed, 293 were categorised as NHL. There was only one case of low grade lymphoma in the series. Over 80% of the cases fell into the categories Burkitt lymphoma (42.2%), lymphoblastic lymphoma (27.2%) and anaplastic large cell lymphoma (15.1%). Cases of Burkitt lymphoma presented most often with abdominal tumours mainly of the ileocaecal region. Tumours of the oropharynx and nasopharynx were also common in this group. Of the 84 lymphoblastic lymphomas, 56 were of the T-cell phenotype, 12 of the B-cell phenotype and 16 of indeterminate lineage. Most of the T-lymphoblastic lymphomas showed mediastinal or pleural involvement. Infiltration of the skin and soft tissues was seen in 25% of lymphoblastic lymphoma of B or indeterminate phenotype. Forty six children were diagnosed as having anaplastic large cell lymphoma, the majority being of T or indeterminate lineage. Most patients presented with lymphadenopathy but involvement of the bones, soft tissues or skin was seen in seven patients and of the mediastinum and lungs in five. CONCLUSION: Childhood non-Hodgkin lymphomas are almost all high grade and frequently extranodal. They fall mainly into the categories Burkitt lymphoma, lymphoblastic lymphoma and anaplastic large cell lymphoma. The separation of these subcategories can be made on the basis of morphology and immunohistochemical features. The anatomical distribution of these different categories of non-Hodgkin lymphoma is distinctive.
Relevant Article
J. Clin. Pathol. 1997 50: 709.
This article has been cited by other articles:
![]() |
M.-C. Le Deley, A. Reiter, D. Williams, G. Delsol, I. Oschlies, K. McCarthy, M. Zimmermann, L. Brugieres, and on behalf of the European Intergroup for Childhood Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study Blood, February 1, 2008; 111(3): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellan, S. Lazzi, M. Hummel, N. Palummo, M. de Santi, T. Amato, J. Nyagol, E. Sabattini, T. Lazure, S. A. Pileri, et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas Blood, August 1, 2005; 106(3): 1031 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Seidemann, M. Tiemann, I. Lauterbach, G. Mann, I. Simonitsch, K. Stankewitz, M. Schrappe, M. Zimmermann, C. Niemeyer, R. Parwaresch, et al. Primary Mediastinal Large B-Cell Lymphoma With Sclerosis in Pediatric and Adolescent Patients: Treatment and Results From Three Therapeutic Studies of the Berlin-Frankfurt-Munster Group J. Clin. Oncol., May 1, 2003; 21(9): 1782 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, and L Leoncini Burkitt's lymphoma: new insights into molecular pathogenesis J. Clin. Pathol., March 1, 2003; 56(3): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J.I. McGill and C.-L. Wu Case 19-2002 - A 13-Year-Old Girl with a Mass in the Left Parotid Gland and Regional Lymph Nodes N. Engl. J. Med., June 20, 2002; 346(25): 1989 - 1996. [Full Text] [PDF] |
||||
![]() |
H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features Blood, December 1, 2000; 96(12): 3681 - 3695. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cinti, L. Leoncini, A. Nyongo, F. Ferrari, S. Lazzi, C. Bellan, R. Vatti, A. Zamparelli, G. Cevenini, G. M. T osi, et al. Genetic Alterations of the Retinoblastoma-Related Gene RB2/p130 Identify Different Pathogenetic Mechanisms in and among Burkitt’s Lymphoma Subtypes Am. J. Pathol., March 1, 2000; 156(3): 751 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.H. Wright What Is Burkitt's Lymphoma and When Is It Endemic? Blood, January 15, 1999; 93(2): 758 - 759. [Full Text] [PDF] |
||||
![]() |
L. Brugieres, M.C. L. Deley, H. Pacquement, Z. Meguerian-Bedoyan, M.J. Terrier-Lacombe, A. Robert, C. Pondarre, G. Leverger, C. Devalck, C. Rodary, et al. CD30+ Anaplastic Large-Cell Lymphoma in Children: Analysis of 82 Patients Enrolled in Two Consecutive Studies of the French Society of Pediatric Oncology Blood, November 15, 1998; 92(10): 3591 - 3598. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |